⚡ This is your brand? Claim your page FREE and bring it to life on AI search.
AEO Score: 4/10
Monitoring for AI engine activity
In the Engagemii AEO index
Your AEO score measures whether AI search engines (ChatGPT, Claude, Perplexity, Gemini) can actually read your site and cite it in answers. Two-thirds of websites are invisible to them. Soteria BioTherapeutics just got measured.
4/10 means Soteria BioTherapeutics is borderline visible. AI bots can crawl your site but your structured-data signals are thin. You are at risk of being skipped when buyers ask AI for a recommendation.
Directors Scientific Advisory Board Investors TECHNOLOGYExpand Technology overview Publications NEWSROOM CAREERS CONTACT PRODUCTSExpand Argentina Colombia Soteria BioTherapeutics Toggle Menu Developing switchable bispecific T-cell engagers to fight cancer Who we are We are an immuno-oncology company developing a next generation of bispecific T-cell engagers to treat patients with solid tumor cancers.
2
Structured Data
2
Content Structure
5
Entity Clarity
5
E-E-A-T Signals
5
Technical AEO
2
AI Discoverability
Is this your brand?
Claim free. You'll see:
Your full 6-category score breakdown
Exact fixes: robots.txt, schema, llms.txt
AI bot crawls from ChatGPT, Claude, Perplexity, Gemini
Personal 50% off code at checkout
Tech buyers are the most research-intensive shoppers on the internet.
Continue reading in your free Engagemii portalFree signup unlocks the full article plus your personalized AEO fix list for Soteria BioTherapeutics.
Scored by Engagemii on June 28, 2026. Methodology: engagemii.com/aeo/methodology
Source URL: https://engagemii.com/aeo/brands/soteriabiotherapeutics
Cite this score: Engagemii (2026). "AEO Score for Soteria BioTherapeutics." Retrieved from https://engagemii.com/aeo/brands/soteriabiotherapeutics
Licensed under CC BY 4.0. You may reuse this data with attribution: a visible link to engagemii.com.
Powered by Engagemii - AI Brand Discovery and AEO Platform